Surgically‐related severe adverse effects (grade 3+) ‐ bowel resection (within 30 days of surgery) · women with advanced ovarian epithelial cancer
Neoadjuvant chemotherapy prior to interval surgery (NACT) probably leads to lower surgically‐related severe adverse effects (grade 3+) ‐ bowel… compared with surgery followed by chemotherapy (PDS) (moderate certainty).
1 finding from 1 review
Surgically‐related severe adverse effects (grade 3+) ‐ postoperative G3+ events (within 30 days of surgery) · women with advanced ovarian epithelial cancer
Neoadjuvant chemotherapy prior to interval surgery (NACT) probably leads to lower surgically‐related severe adverse effects (grade 3+) ‐ postoperative… compared with surgery followed by chemotherapy (PDS) (moderate certainty).
1 finding from 1 review
Surgically‐related postoperative mortality (28 days to 6 months of surgery4) · women with advanced ovarian epithelial cancer
Neoadjuvant chemotherapy prior to interval surgery (NACT) leads to lower surgically‐related postoperative mortality (28 days to 6 months of… compared with surgery followed by chemotherapy (PDS) (high certainty).
1 finding from 1 review
Adverse events (4 weeks' to 180 days' · primary Raynaud's phenomenon
1 finding from 1 review
Duration of attacks per day (minutes) · primary Raynaud's phenomenon
1 finding from 1 review
Migraine frequency Number of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Severity of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Proportion discharged as day surgery · people undergoing laparoscopic cholecystectomy.
It is very uncertain whether summary of findings table ‐ Intraperitoneal local anaesthetic changes proportion discharged as day surgery compared with control (very low certainty).
1 finding from 1 review
Mortality at 30 days following the ingestion of paraquat · people with moderate to severe oral paraquat poisoning
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oxygen efficiency (PaO2/FiO2) day 1 postoperative · patients with ALI and ARDS
1 finding from 1 review
Oxygen efficiency (PaO2/FiO2) day 3 postoperative · patients with ALI and ARDS
1 finding from 1 review
Oxygen efficiency (PaO2/FIO2). Day 7 · patients with ALI and ARDS
1 finding from 1 review
Ventilator‐free days up to day 28 · patients with ALI and ARDS
1 finding from 1 review
Maternal death · mothers and infants receiving home visits in the early postpartum period
It is very uncertain whether schedules involving more changes maternal mortality within 42 days post‐birth compared with fewer home visits (very low certainty).
1 finding from 1 review
Postnatal depression · mothers and infants receiving home visits in the early postpartum period
1 finding from 1 review
Hospital days per patient, all causes · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Relapse · children, aged 2 to 59 months, with WHO‐defined non‐severe pneumonia and wheeze
Antibiotic therapy showed no clear difference in relapse (children who were 'cured' but developed symptoms within… compared with placebo compared to placebo (low certainty).
1 finding from 1 review
Adverse effects of antibiotics · children, aged 2 to 59 months, with WHO‐defined non‐severe pneumonia and wheeze
Antibiotic therapy showed no clear difference in treatment harms (adverse events or side effects associated with… compared with placebo compared to placebo (low certainty).
1 finding from 1 review
Intervention not reported
Duration of supplemental oxygen (days) · preterm infants less than 30 weeks' gestational age requiring conventional mechanical ventilation for respiratory distress syndrome
1 finding from 1 review
Intervention not reported
Duration of ventilatory support (days) · preterm infants less than 30 weeks' gestational age requiring conventional mechanical ventilation for respiratory distress syndrome
1 finding from 1 review